News
Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk (NASDAQ:SNY)
This article was written byFollowWith a background as a RN, I analyze healthcare-related stocks by evaluating clinical data, treatment guidelines,…
Editor's Top Picks
Worthington Enterprises: Upgrade To Buy On Improved Fundamentals (NYSE:WOR)
This article was written byFollowI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach…
Your one-stop resource for personal news and tips.
More form News
Buy The Upside Breakout In Microsoft (Technical Analysis) (NASDAQ:MSFT)
Microsoft Corporation (NASDAQ:MSFT) enjoyed remarkable financial growth in 2022. The tech giant's substantial revenue and…
Western capitals must keep lines open to Moscow
Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up…
My Top Ten Personal Holdings (NYSE:XFLT)
My Top 10 Personal Holdings Many readers have expressed interest in my personal investments, and…
Microsoft to face EU competition probe over Teams and Office bundling
Receive free EU tech regulation updatesWe’ll send you a myFT Daily Digest email rounding up…
Molina Healthcare: A Hidden Compounder In Managed Healthcare (NYSE:MOH)
Investment Thesis Molina Healthcare (NYSE:MOH) has been a hidden compounder in the past decade, with…
Russia pulls out of Black Sea grain deal
Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up…
Intellicheck: SaaS Growth Could Create An Attractive Opportunity (NASDAQ:IDN)
Intellicheck (NASDAQ:IDN) provides identity verification software for retail locations and online use cases. I believe…
Russia halts traffic over Crimea bridge after reports of explosion
Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up…
Alector: Immuno-Neurology Innovator But Wait For The Pipeline Success (NASDAQ:ALEC)
Company Overview Alector (NASDAQ:ALEC), a biopharmaceutical company in clinical stage, is pioneering immuno-neurology to treat…
Wall St is divided over just how bad Goldman’s earnings will be
Receive free Goldman Sachs Group updatesWe’ll send you a myFT Daily Digest email rounding up…
SGOV: Safe Haven And Tactical Cash Holding
Due to the Federal Reserve's tightening of monetary policy, interest rate risk has become a…
EU pushes other polluting nations to cut emissions faster
Receive free Climate change updatesWe’ll send you a myFT Daily Digest email rounding up the…
Village Super Market: Mr. Market Misunderstands This One (NASDAQ:VLGEA)
One of the most fascinating things to watch in the market is a company that…
Typo leaks millions of US military emails to Mali web operator
Millions of US military emails have been misdirected to Mali through a “typo leak” that…
Puma Biotechnology: Cheap But Quite Risky (NASDAQ:PBYI)
Introduction Puma Biotechnology (NASDAQ:PBYI) is a biopharmaceutical firm focused on enhancing cancer care through innovative…